INTENSITY THERAPEUTICS INC (INTS) Institutional Shareholders
INTENSITY THERAPEUTICS INC (INTS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.76M in INTS holdings during the latest filing period.
Kmt Wealth Management, Llc is currently the largest disclosed institutional shareholder of INTS tracked by InsiderSet, reporting ownership valued at approximately $2.04M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $2.04M, representing an estimated gain of +0.24% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed INTS value among the investors covered in this analysis. Major shareholders include Kmt Wealth Management, Llc, Rothschild Wealth Llc, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in INTENSITY THERAPEUTICS INC (INTS).
This page ranks the largest institutional INTS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
16
Total Reported Value
$2.76M
Largest Holder
Kmt Wealth Management, Llc
Largest Position
$2.04M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
42
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Kmt Wealth Management, Llc | 1.72% | 496,493 | $2,035,621 | $2,040,586 | +$4,965 | +0.24% | |
| Rothschild Wealth Llc | 0.01% | 26,723 | $109,564 | $109,832 | +$268 | +0.24% | |
| Vanguard Capital Management Llc | 0.00% | 26,569 | $108,933 | $109,199 | +$266 | +0.24% | |
| Sapient Capital Llc | 0.00% | 26,006 | $106,625 | $106,885 | +$260 | +0.24% | |
| Nano Cap New Millennium Growth Fund L P | 0.08% | 25,000 | $102,500 | $102,750 | +$250 | +0.24% | |
| Geode Capital Management, Llc | 0.00% | 22,787 | $93,426 | $93,655 | +$229 | +0.24% | |
| Fny Investment Advisers, Llc | 0.03% | 22,000 | $90,000 | $90,420 | +$420 | +0.47% | |
| Mesirow Financial Investment Management, Inc. | 0.00% | 14,118 | $57,884 | $58,025 | +$141 | +0.24% | |
| Vanguard Fiduciary Trust Co | 0.00% | 9,121 | $37,396 | $37,487 | +$91 | +0.24% | |
| Tower Research Capital Llc (Trc) | 0.00% | 1,984 | $8,134 | $8,154 | +$20 | +0.25% | |
| Newedge Advisors, Llc | 0.00% | 1,148 | $4,707 | $4,718 | +$11 | +0.24% | |
| Osaic Holdings, Inc. | 0.00% | 200 | $820 | $822 | +$2 | +0.24% | |
| Barclays Plc | 0.00% | 42 | $172 | $173 | +$1 | +0.36% | |
| Morgan Stanley | 0.00% | 20 | $82 | $82 | +$0 | +0.24% | |
| Caitong International Asset Management Co., Ltd | 0.00% | 6 | $25 | $25 | -$0 | -1.36% | |
| Ubs Group Ag | 0.00% | 1 | $4 | $4 | +$0 | +2.75% |
Frequently asked questions about INTS
Who owns the most INTS stock?
The largest holders of INTS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for INTENSITY THERAPEUTICS INC (INTS).
Is INTS widely held by superinvestors?
Many widely followed stocks like INTS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly INTS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.